Update on cultured autologous tumor cells and dendritic cells as patient-specific vaccines in recurrent or metastatic melanoma or renal cell cancer

被引：0
|
作者：
Dillman, R [1 ]
Selvan, S [1 ]
Schiltz, P [1 ]
Allen, K [1 ]
DePriest, C [1 ]
Beatty, A [1 ]
de Leon, C [1 ]
Beutel, L [1 ]
Peterson, C [1 ]
Ellis, R [1 ]
机构：
[1] Hoag Mem Hosp Presbyterian, Hoag Canc Ctr, Newport Beach, CA USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2003年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 50 条
  • [21] Patient-specific vaccines derived from autologous tumor cell lines as active specific immunotherapy: Results of exploratory phase I/II trials in patients with metastatic melanoma
    Dillman, Robert O.
    DePriest, Carol
    DeLeon, Cristina
    Barth, Neil M.
    Schwartzberg, Lee S.
    Beutel, Linda D.
    Schiltz, Patric M.
    Nayak, Shankar K.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2007, 22 (03) : 309 - 321
  • [22] Patient-specific immunotherapy utilizing putative tumor stem cells in patients with metastatic melanoma: A pooled analysis comparing tumor cell and dendritic cell vaccines in two phase II trials and a randomized phase II trial.
    Dillman, Robert Owen
    DePriest, Carol
    de Leon, Cristina
    Barth, Neil M.
    McClay, Edward Francis
    Amatruda, Thomas
    Schwartzberg, Lee Steven
    Sheehy, Patrick Frank
    Mahdavi, Khosrow
    Mayorga, Cheryl Ann
    Ellis, Robin Anne
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [23] Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?
    Pawel Kalinski
    Howard Edington
    Herbert J. Zeh
    Hideho Okada
    Lisa H. Butterfield
    John M. Kirkwood
    David L. Bartlett
    Immunologic Research, 2011, 50 : 235 - 247
  • [24] Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?
    Kalinski, Pawel
    Edington, Howard
    Zeh, Herbert J.
    Okada, Hideho
    Butterfield, Lisa H.
    Kirkwood, John M.
    Bartlett, David L.
    IMMUNOLOGIC RESEARCH, 2011, 50 (2-3) : 235 - 247
  • [25] Long-term survival for patients with detectable metastatic melanoma at time of treatment with patient-specific tumor stem cell vaccines
    Dillman, Robert Owen
    DePriest, Carol
    Ellis, Robin Anne
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] Autologous Peripheral Blood Mononuclear Cell Recognition of Autologous Proliferating Tumor Cells in the Context of a Patient-Specific Vaccine Trial
    Cornforth, A. N.
    Lee, G.
    Dillman, R. O.
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
  • [27] Dendritic/Tumor Fusion Cells as Cancer Vaccines
    Avigan, David
    Rosenblatt, Jacalyn
    Kufe, Donald
    SEMINARS IN ONCOLOGY, 2012, 39 (03) : 287 - 295
  • [28] Irradiated cells from autologous tumor cell lines as patient-specific vaccine therapy in 125 patients with metastatic cancer: Induction of delayed-type hypersensitivity to autologous tumor is associated with improved survival
    Dillman, RO
    Beutel, LD
    Barth, NM
    de Leon, C
    O'Connor, AA
    DePriest, C
    Nayak, SK
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2002, 17 (01) : 51 - 66
  • [29] Treatment-related adverse events in a randomized trial in stage three and four ovarian cancer testing patient-specific dendritic cell vaccines loaded with tumor antigens from self-renewing autologous tumor cells
    Corr, Bradley
    Abaid, Lisa
    Mason, James
    Eskander, Ramez
    Cappuccini, Fabio
    Friedman, Richard
    Lopez, Katrina
    Nistor, Gabriel
    Dillman, Robert
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S164 - S164
  • [30] Generation of hybrid cells by fusion of allogeneic dendritic cells with autologous tumor cells and first clinical use in patients with metastatic melanoma
    Trefzer, U
    Schlegel, C
    Noack, K
    Adrian, K
    Sterry, W
    Walden, P
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (03) : 432 - 432
12345